ImmuCell
Portland
About ImmuCell
ImmuCell has a dedicated group of employees who are actively developing, manufacturing and selling innovative products such as First Defense®, the #1 product administered to calves for scours prevention. Our corporate capabilities and technical expertise include the following:
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $20.0M
- Funding stage: IPO
- Last round: Post-IPO Debt (Aug 2025)
- Ticker: nasdaq:ICCC
- Website: immucell.com
- Phone: (207) 786-2914
Industries & Categories
Employee Benefits, Innovation Management, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/immucell-82239 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.